2022《NCC N遗传性/家族性卵巢癌风险评估与临床管理指南（第1版）》解读

2022-08-15 四川大学华西第二医院妇科出生缺陷与相关妇儿疾病教育部重点实验室实用妇产科杂志

卵巢癌发病率居女性生殖系统恶性肿瘤第3位，死亡率居妇科恶性肿瘤之首

中文标题：

发布机构：

四川大学华西第二医院妇科出生缺陷与相关妇儿疾病教育部重点实验室

发布日期：

2022-08-15

简要介绍：

卵巢癌发病率居女性生殖系统恶性肿瘤第3位，死亡率居妇科恶性肿瘤之首^[1]。约10%～24%的卵巢癌与特定基因的胚系突变有关^[2～5],这种发生在生殖细胞或早期受精卵的基因突变具有家族遗传性^[6]。随着遗传学和分子生物学的进步，目前已经发现许多与遗传性卵巢癌相关的基因，携带特定基因突变的人群患卵巢癌的风险明显高出普通人群^[2],因此对遗传性卵巢癌高危人群进行癌症风险评估与遗传咨询很有必要。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=e9a3d1c0026131b1, title=2022《NCC N遗传性/家族性卵巢癌风险评估与临床管理指南（第1版）》解读, enTitle=, guiderFrom=实用妇产科杂志, authorId=0, author=, summary=卵巢癌发病率居女性生殖系统恶性肿瘤第3位，死亡率居妇科恶性肿瘤之首, cover=https://img.medsci.cn/20220820/1660965288517_1608702.png, journalId=0, articlesId=null, associationId=3098, associationName=四川大学华西第二医院妇科出生缺陷与相关妇儿疾病教育部重点实验室, associationIntro=四川大学华西第二医院妇科出生缺陷与相关妇儿疾病教育部重点实验室, copyright=0, guiderPublishedTime=Mon Aug 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=卵巢癌发病率居女性生殖系统恶性肿瘤第3位，死亡率居妇科恶性肿瘤之首[1]。约10%～24%的卵巢癌与特定基因的胚系突变有关[2～5],这种发生在生殖细胞或早期受精卵的基因突变具有家族遗传性[6]。随着遗传学和分子生物学的进步，目前已经发现许多与遗传性卵巢癌相关的基因，携带特定基因突变的人群患卵巢癌的风险明显高出普通人群[2],因此对遗传性卵巢癌高危人群进行癌症风险评估与遗传咨询很有必要。, tagList=[TagDto(tagId=359, tagName=卵巢癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2801, appHits=40, showAppHits=0, pcHits=441, showPcHits=2758, likes=0, shares=6, comments=3, approvalStatus=1, publishedTime=Tue Aug 23 10:12:00 CST 2022, publishedTimeString=2022-08-15, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=7, createdBy=null, createdName=dajiong, createdTime=Sat Aug 20 11:15:07 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 11:23:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022《NCCN遗传性_家族性卵巢癌风险评估与临床管理指南（第1版）》解读.pdf)])

2022《NCCN遗传性_家族性卵巢癌风险评估与临床管理指南（第1版）》解读.pdf

下载请点击：

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2104373, encodeId=280521043e3e5, content=如何积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81728464993, createdName=ms2000000753087000, createdTime=Mon Dec 05 11:25:50 CST 2022, time=2022-12-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1242485, encodeId=734512424856f, content=hhh, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d415459151, createdName=ms2000001300428387, createdTime=Thu Sep 01 13:38:59 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242157, encodeId=80c4124215ec6, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:20:13 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
2022-12-05 ms2000000753087000 来自陕西省

如何积分

78 0
[GetPortalCommentsPageByObjectIdResponse(id=2104373, encodeId=280521043e3e5, content=如何积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81728464993, createdName=ms2000000753087000, createdTime=Mon Dec 05 11:25:50 CST 2022, time=2022-12-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1242485, encodeId=734512424856f, content=hhh, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d415459151, createdName=ms2000001300428387, createdTime=Thu Sep 01 13:38:59 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242157, encodeId=80c4124215ec6, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:20:13 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
2022-09-01 ms2000001300428387

hhh

81 0
[GetPortalCommentsPageByObjectIdResponse(id=2104373, encodeId=280521043e3e5, content=如何积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81728464993, createdName=ms2000000753087000, createdTime=Mon Dec 05 11:25:50 CST 2022, time=2022-12-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1242485, encodeId=734512424856f, content=hhh, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d415459151, createdName=ms2000001300428387, createdTime=Thu Sep 01 13:38:59 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242157, encodeId=80c4124215ec6, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Tue Aug 30 22:20:13 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
2022-08-30 ms4000001291803254

很实用

79 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤指南

2022《NCC N遗传性/家族性卵巢癌风险评估与临床管理指南（第1版）》解读

相关指南

科室

工具

服务